2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Head and Neck Neoplasms
4
Esophageal Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Ovarian Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Urologic Neoplasms
1
Triple Negative Breast Neoplasms
1
Thoracic Diseases
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prolactinoma
1
Pituitary ACTH Hypersecretion
1
Peritoneal Diseases
1
Paraproteinemias
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Diseases
1
Neuroblastoma
1
Nervous System Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Mesothelioma, Malignant
1
Lymphoma
1
Interventions
Nivolumab
14
Ipilimumab
11
Specimen Handling
10
CTLA-4 Antigen
7
pembrolizumab
6
cabozantinib
6
Sunitinib
6
Magnetic Resonance Spectroscopy
6
Axitinib
5
pazopanib
4
Biopsy
4
Radiosurgery
3
lenvatinib
2
fludarabine
2
Everolimus
2
Blood Specimen Collection
2
tivozanib
1
sodium-iodide symporter
1
sitravatinib
1
belzutifan
1
atezolizumab
1
aldesleukin
1
Zoledronic Acid
1
Tissue Banks
1
Selenomethionine
1
Radiotherapy
1
Radiopharmaceuticals
1
Pluvicto
1
Nephrectomy
1
Molecular Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Clear-cell metastatic renal cell carcinoma
×
Tissue Banks
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled